Search Results - "Tzouvara, E."

P-260 Exposure to pesticides is a major risk factor for myelodysplastic syndromes (MDS) in Southwestern Greece by Avgerinou, C, Kouraklis, A, Theodoropoulou, S, Giannezi, I, Lazaris, V, Lampropoulou, P, Labropoulou, V, Tzouvara, E, Zikos, P, Alamanos, Y, Karakantza, M, Symeonidis, A

Get full text

Human herpesvirus 6‐related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet by Lagadinou, E.D., Marangos, M., Liga, M., Panos, G., Tzouvara, E., Dimitroulia, E., Tiniakou, M., Tsakris, A., Zoumbos, N., Spyridonidis, A.

“…E.D. Lagadinou, M. Marangos, M. Liga, G. Panos, E. Tzouvara, E. Dimitroulia, M. Tiniakou, A. Tsakris, N. Zoumbos, A. Spyridonidis. Human herpesvirus 6‐related…”
Get full text

C017 Expression of proteins p16INK4a, p53 and Bmi-1 in hematopoietic stem cells of patients with MDS. The role of cellular senescence by Constandinidou, I, Kalivioti, E, Fertakis, V, Dallas, C, Lampropoulou, P, Tzouvara, E, Zoumboulis, P, Zoumbos, N

Get full text

A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001 by Alymara, V, Tzouvara, E, Vartholomatos, G, Chaidos, A, Tsiara, St, Bourantas, K L

“…Acute myeloid leukemia (AML) predominantly affects older adults, a population with a poor prognosis, due to age, comorbidities and forms of disease. We present…”
Get more information

Antierythropoietin antibodies in thalassemia patients by Voulgari, P V, Chaidos, A, Tzouvara, E, Alymara, V, Alamanos, Y, Drosos, A A, Bourantas, K L

“…We evaluated sera from 58 thalassemic patients for the presence of antierythropoietin antibodies to investigate whether these autoantibodies may relate with…”
Get full text

Alemtuzumab 20 mg only in vivo confers efficient GvHD prophylaxis in sibling and matched unrelated HCT by Spyridonidis, A, Karakantza, M, Symeonidis, A, Triantafyllou, E, Tzouvara, E, Kourakli, A, Tiniakou, M, Zoumbos, N

“…Despite standard CyA/MTX GvHD prophylaxis, severe acute GVHD occurs after ~35% of matched sibling HCT. MTX is associated with mucositis, delayed engraftment…”
Get full text

Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet: HHV-6 and PRCA immune suppression after HCT by Lagadinou, E.D., Marangos, M., Liga, M., Panos, G., Tzouvara, E., Dimitroulia, E., Tiniakou, M., Tsakris, A., Zoumbos, N., Spyridonidis, A.

Get full text

Solitary extramedullary plasmacytoma of the maxillary sinus. Case report by Exarchakos, G, Korantzopoulos, P, Bai, M, Xanthopoulos, J, Tzouvara, E, Skevas, A

“…Solitary extramedullary plasmacytomas are rare tumors that often affect head and neck region. Because of the non-specific associated symptomatology, they…”
Get more information

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules by Chaidos, Aristeidis, Makis, Alexandros, Hatzimichael, Eleftheria, Tsiara, Stavroula, Gouva, Maria, Tzouvara, Evangelia, Bourantas, Konstantinos L

“…The most common single genetic disorder and a major public health issue in Greece and other Mediterranean countries is beta-thalassemia. Current therapeutic…”
Get more information

Effectiveness and safety of combined iron-chelation therapy with deferoxamine and deferiprone by Alymara, Vasiliki, Bourantas, Dimitrios, Chaidos, Aristeidis, Bouranta, Paraskevi, Gouva, Maria, Vassou, Amalia, Tzouvara, Evagelia, Bourantas, Konstantinos L

“…The purpose of our study was to evaluate the effectiveness and safety of combined therapy with deferoxamine (DFO) and deferiprone (DFP) in patients with…”
Get more information

Thalidomide administration for the treatment of resistant plasma cell leukemia by Tsiara, Stavroula, Chaidos, Aristeidis, Kapsali, Helen, Tzouvara, Evagelia, Bourantas, Konstantinos L

Get more information

Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet by Lagadinou, E.D., Marangos, M., Liga, M., Panos, G., Tzouvara, E., Dimitroulia, E., Tiniakou, M., Tsakris, A., Zoumbos, N., Spyridonidis, A.

Get full text